Literature DB >> 18410599

Hepatitis B and fatty liver: causal or coincidental?

Jian-Gao Fan, Shivakumar Chitturi.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18410599     DOI： 10.1111/j.1440-1746.2008.05361.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN： 0815-9319            Impact factor:   4.029


× No keyword cloud information.
  10 in total

1.  Does Hepatic Steatosis Influence the Virological Response with Chronic Hepatitis B Patients Treated with Entecavir or Tenofovir Disoproxil Fumarate?

Authors:  Roni Atalay; Süleyman Sayar; Fatma Gülçiçek Ayrancı; Şüheda Çakmak; İbrahim Halil Tanboğa; Levent Doğanay; Kamil Özdil
Journal:  Turk J Gastroenterol       Date:  2022-07       Impact factor: 1.555

2.  Hepatitis B virus X protein impairs hepatic insulin signaling through degradation of IRS1 and induction of SOCS3.

Authors:  KyeongJin Kim; Kook Hwan Kim; JaeHun Cheong
Journal:  PLoS One       Date:  2010-03-23       Impact factor: 3.240

3.  Hepatic steatosis is highly prevalent in hepatitis B patients and negatively associated with virological factors.

Authors:  Man-Man Wang; Gong-Sui Wang; Feng Shen; Guang-Yu Chen; Qin Pan; Jian-Gao Fan
Journal:  Dig Dis Sci       Date:  2014-05-18       Impact factor: 3.199

4.  Noninvasive Diagnosis of Hepatic Steatosis Using Fat Attenuation Parameter Measured by FibroTouch and a New Algorithm in CHB Patients.

Authors:  Hong Deng; Chun-Ling Wang; Jing Lai; Su-Lin Yu; Dong-Ying Xie; Zhi-Liang Gao
Journal:  Hepat Mon       Date:  2016-07-24       Impact factor: 0.660

5.  Association Between Appendectomy and Fibrosis Progression in Nonalcoholic Fatty Liver Disease.

Authors:  Masakazu Nakano; Toshimitsu Murohisa; Yasuo Imai; Masaya Tamano; Hideyuki Hiraishi
Journal:  Gastroenterology Res       Date:  2013-03-09

6.  The expression of thymosin β4 in chronic hepatitis B combined nonalcoholic fatty liver disease.

Authors:  Jing Liang; Wenjuan Cai; Tao Han; Li Jing; Zhe Ma; Yingtang Gao
Journal:  Medicine (Baltimore)       Date:  2016-12       Impact factor: 1.889

7.  Serum Monounsaturated Triacylglycerol Predicts Steatohepatitis in Patients with Non-alcoholic Fatty Liver Disease and Chronic Hepatitis B.

Authors:  Rui-Xu Yang; Chun-Xiu Hu; Wan-Lu Sun; Qin Pan; Feng Shen; Zhen Yang; Qing Su; Guo-Wang Xu; Jian-Gao Fan
Journal:  Sci Rep       Date:  2017-09-05       Impact factor: 4.379

8.  Advanced Liver Fibrosis Is Associated with Necroinflammatory Grade but Not Hepatic Steatosis in Chronic Hepatitis B Patients.

Authors:  Yi-Cheng Chen; Chao-Wei Hsu; Wen-Juei Jeng; Chun-Yen Lin
Journal:  Dig Dis Sci       Date:  2021-02-10       Impact factor: 3.199

9.  Clinical and virological characteristics of chronic hepatitis B patients with hepatic steatosis.

Authors:  Rui-dan Zheng; Jian-neng Chen; Qun-ying Zhuang; Yan-hui Lu; Jie Chen; Bi-fen Chen
Journal:  Int J Med Sci       Date:  2013-03-25       Impact factor: 3.738

10.  Impact of hepatic steatosis on treatment response in nuclesos(t)ide analogue-treated HBeAg-positive chronic hepatitis B: a retrospective study.

Authors:  Yi-Cheng Chen; Wen-Juei Jeng; Chao-Wei Hsu; Chun-Yen Lin
Journal:  BMC Gastroenterol       Date:  2020-05-12       Impact factor: 3.067
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.